Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer

SIMPLE SUMMARY: In high-grade serous ovarian cancer (HGSOC), the PARP (poly(ADP-ribose) polymerase) inhibitor resistance limits the therapeutic strategies. Understanding the regulation of PARP1 expression in HGSOC may be functional to overcome this issue. We recently demonstrated that, in cervical c...

Descripción completa

Detalles Bibliográficos
Autores principales: Raspaglio, Giuseppina, Buttarelli, Marianna, Cappoli, Natalia, Ciucci, Alessandra, Fagotti, Anna, Scambia, Giovanni, Gallo, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137242/
https://www.ncbi.nlm.nih.gov/pubmed/37190289
http://dx.doi.org/10.3390/cancers15082361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137242/
https://www.ncbi.nlm.nih.gov/pubmed/37190289
http://dx.doi.org/10.3390/cancers15082361

Ejemplares similares